Mounjaro
NDC 0002-1152 · Eli Lilly and Company
Generic nametirzepatide
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)TIRZEPATIDE
Strength2.5 mg/.5mL
Pharmacologic classG-Protein-linked Receptor Interactions [MoA], GLP-1 Receptor Agonist [EPC], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Glucose-dependent Insulinotropic Polypeptide Receptor Agonist [EPC]
Marketing categoryNDA
Packages
0002-1152-01 — 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-1152-01) / .5 mL in 1 VIAL, SINGLE-DOSE
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
0002-0152 — tirzepatide, 0002-0243 — tirzepatide, 0002-1214 — tirzepatide, 0002-1243 — tirzepatide, 0002-1340 — tirzepatide, 0002-1423 — tirzepatide, 0002-1457 — tirzepatide, 0002-1460 — tirzepatide, 0002-1471 — tirzepatide, 0002-1484 — tirzepatide, 0002-1495 — tirzepatide, 0002-1506 — tirzepatide, 0002-2002 — tirzepatide, 0002-2214 — tirzepatide, 0002-2340 — tirzepatide, 0002-2423 — tirzepatide, 0002-2457 — tirzepatide, 0002-2460 — tirzepatide, 0002-2471 — tirzepatide, 0002-2484 — tirzepatide, +33 more